Filing Details
- Accession Number:
- 0001209191-18-011097
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-20 08:31:59
- Reporting Period:
- 2018-02-14
- Accepted Time:
- 2018-02-20 08:31:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
818686 | Teva Pharmaceutical Industries Ltd | TEVA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1721442 | Mark Sabag | C/O Teva Pharmaceutical Industries Ltd. 5 Basel Street Petach Tikva L3 4951033 | Evp, Global Human Resources | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares | Disposition | 2018-02-14 | 2,050 | $18.45 | 44,517 | No | 4 | S | Direct | |
Ordinary Shares | Disposition | 2018-02-15 | 3,000 | $20.52 | 41,517 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.43 to $18.47.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.54 to $20.50.